Evidence map›Paper›PMID 38307943›Full record

ArticleScientific reports2024

Zinc oxide resveratrol nanoparticles ameliorate testicular dysfunction due to levofloxacin-induced oxidative stress in rats.

Naglaa F Zaki, Sahar H Orabi, Hend Mohamed Abdel-Bar, Hamed T Elbaz, Reda M S Korany, Ayman K Ismail, Walid M Daoush, Maram H Abduljabbar, Manal E Alosaimi, Reem M Alnemari and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Unveiling the Potential of Silymarin,Life (Basel, Switzerland) · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Naglaa F ZakiDepartment of Biochemistry and Chemistry of Nutrition, Faculty of Veterinary Medicine, University of Sadat City, Sadat City, Egypt.
Sahar H OrabiDepartment of Biochemistry and Chemistry of Nutrition, Faculty of Veterinary Medicine, University of Sadat City, Sadat City, Egypt.
Hend Mohamed Abdel-BarDepartment of Pharmaceutics, Faculty of Pharmacy, University of Sadat City, Sadat City, Egypt.
Hamed T ElbazDepartment of Theriogenology, Faculty of Veterinary Medicine, University of Sadat City, Sadat City, Egypt.
Reda M S KoranyDepartment of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
Ayman K IsmailDepartment of Forensic Medicine and Toxicology, College of Veterinary Medicine, Suez Canal University, PO Box 41522, Ismailia, Egypt.
Walid M DaoushDepartment of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), P.O. Box 90950, 11623, Riyadh, Saudi Arabia.
Maram H AbduljabbarDepartment of Pharmacology and Toxicology, College of Pharmacy, Taif University, 21944, Taif, Saudi Arabia.
Manal E AlosaimiDepartment of Basic Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, P.O. Box 84428, 11671, Riyadh, Saudi Arabia. Mealosaimi@pnu.edu.sa.
Reem M AlnemariDepartment of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, Taif University, 21944, Taif, Saudi Arabia.
Heba H MahboubDepartment of Aquatic Animal Medicine, Faculty of Veterinary Medicine, Zagazig University, PO Box 44511, Zagazig, Sharkia, Egypt.
Mohamed M AhmedDepartment of Biochemistry and Chemistry of Nutrition, Faculty of Veterinary Medicine, University of Sadat City, Sadat City, Egypt.
University of Sadat City · EGTaif University · SACairo University · EGHelwan University · EGPrincess Nourah bint Abdulrahman University · SASuez Canal University · EGZagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present work is aimed to assess the protective influence of zinc oxide resveratrol nanoparticles against oxidative stress-associated testicular dysfunction. The number of 50 male albino rats were randomly separated into five groups (n = 10): Group I, control: rats gavage distilled water orally; Group II, Levofloxacin: rats that administered Levofloxacin (LFX) softened in distilled water at a dosage of 40 mg/kg

Indexed as

NanoparticlesTesticular DiseasesZinc OxideAnimalsAntioxidantsCatalaseFollicle Stimulating HormoneHumansLevofloxacinLuteinizing HormoneMaleMalondialdehydeOxidative StressRatsRats, WistarResveratrolAntioxidantsCatalaseFollicle Stimulating HormoneLevofloxacinLuteinizing HormoneMalondialdehydeResveratrolSuperoxide DismutaseTestosteroneWaterZinc Oxide

Identifiers

PMID38307943
PMCPMC10837121
OpenAlexW4391483012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.